We posit that metabolic reprogramming regulated by RON/DEK/β-catenin may be similarly controlled by other oncogenic drivers of metastasis/recurrence and may therefore more broadly define key metabolic drivers of breast cancer stages responsible for the majority of cancer-related deaths. The gene discussed is MST1R; the disease is cancer.